TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis
Harvard University publishes research in tuberculosis
July 8th, 2008
According to recent research published in the journal Clinical Infectious Diseases, "Completing treatment for multidrug-resistant (MDR) tuberculosis (TB) may be more challenging than completing first-line TB therapy, especially in resource-poor settings. The objectives of this study were to (1) identify risk factors for default from MDR TB therapy (defined as prolonged treatment interruption), (2) quantify mortality among patients who default from treatment, and (3) identify risk factors for death after default from treatment." "We performed a retrospective chart review to identify risk factors for default from MDR TB therapy and conducted home visits to assess...
Source: TB & Outbreaks Week (2008-07-08)
|
